Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 2
NIH IMPROVE Initiative maternal health research program
Directs the National Institutes of Health (NIH) Director to continue carrying out the IMPROVE Initiative — a research program targeting maternal mortality, severe maternal morbidity, and health disparities — by advancing evidence-based interventions, identifying biological and behavioral risk factors, and implementing community-based strategies for disproportionately affected populations.
- Population Scope Medium Directly affects pregnant and postpartum women — roughly 3-4 million births per year in the U.S. — plus researchers and community organizations serving them, a meaningful but well-under-25% share of the population.
- Budgetary Magnitude Low The programmatic mandate itself carries no dollar figure; funding is addressed in the separate authorization provision (component 1).
- Legal / Regulatory Depth High Creates a new statutory duty on the National Institutes of Health (NIH) Director — a binding 'shall continue' mandate with defined objectives — embedding the IMPROVE Initiative permanently in the Public Health Service Act.
- Degree of Discretion Granted Medium The 'shall' mandate fixes the obligation, but implementation authority is broad — NIH Director 'may' award grants, contracts, cooperative agreements, or other transactions with wide latitude over design and targeting.
- Implementation & Enforcement Burden Low Imposes no new enforcement infrastructure or compliance obligations; burden is internal to NIH grant administration already in routine operation.
- Temporal Commitment High The programmatic mandate has no expiration date and persists until Congress affirmatively repeals it.
No signal yet
Funding / Appropriations Top 2
IMPROVE Initiative $73.4M annual authorization FY2026-2031
Authorizes $73,400,000 per fiscal year for fiscal years 2026 through 2031 to carry out the IMPROVE Initiative maternal health research program established in new 42 U.S.C. § 409K.
- Population Scope Medium Funds flow to researchers, grantees, and community organizations serving pregnant and postpartum women — the same bounded population as the programmatic mandate, well under 25% of the U.S. population.
- Budgetary Magnitude Medium Authorizes $73.4 million per year for six years ($440.4 million total), a recurring discretionary authorization of moderate scale within the broader National Institutes of Health (NIH) budget.
- Legal / Regulatory Depth Low Sets a dollar ceiling for an already-authorized program without altering substantive rights, duties, or enforcement authority — a narrow administrative act that constrains appropriators rather than changing underlying law.
- Degree of Discretion Granted Low The provision fixes a maximum annual figure with no delegated flexibility; actual spending is subject to the appropriations process, leaving no discretion within this clause itself.
- Implementation & Enforcement Burden Low An authorization ceiling creates no new enforcement mechanism, compliance requirement, or administrative infrastructure.
- Temporal Commitment Low The authorization expires by its own terms after FY2031 — a hard, six-year window that self-terminates unless Congress acts to extend it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
The National Institutes of Health (NIH) IMPROVE Act formally codifies and continues the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative within NIH, directing NIH Director to carry out a research program aimed at reducing maternal mortality, severe maternal morbidity, and related health disparities. The bill authorizes $73.4 million annually for fiscal years 2026 through 2031 to fund grants, contracts, cooperative agreements, and other transactions in support of community-based interventions and biological research targeting the leading causes of poor maternal outcomes.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Nov 20, 2025
|
Nov 20, 2025 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 2
NIH IMPROVE Initiative maternal health research program
Directs the National Institutes of Health (NIH) Director to continue carrying out the IMPROVE Initiative — a research program targeting maternal mortality, severe maternal morbidity, and health disparities — by advancing evidence-based interventions, identifying biological and behavioral risk factors, and implementing community-based strategies for disproportionately affected populations.
- Population Scope Medium Directly affects pregnant and postpartum women — roughly 3-4 million births per year in the U.S. — plus researchers and community organizations serving them, a meaningful but well-under-25% share of the population.
- Budgetary Magnitude Low The programmatic mandate itself carries no dollar figure; funding is addressed in the separate authorization provision (component 1).
- Legal / Regulatory Depth High Creates a new statutory duty on the National Institutes of Health (NIH) Director — a binding 'shall continue' mandate with defined objectives — embedding the IMPROVE Initiative permanently in the Public Health Service Act.
- Degree of Discretion Granted Medium The 'shall' mandate fixes the obligation, but implementation authority is broad — NIH Director 'may' award grants, contracts, cooperative agreements, or other transactions with wide latitude over design and targeting.
- Implementation & Enforcement Burden Low Imposes no new enforcement infrastructure or compliance obligations; burden is internal to NIH grant administration already in routine operation.
- Temporal Commitment High The programmatic mandate has no expiration date and persists until Congress affirmatively repeals it.
No signal yet
Core Policy Mechanism
NIH IMPROVE Initiative maternal health research program
Funding / Appropriations Top 2
IMPROVE Initiative $73.4M annual authorization FY2026-2031
Authorizes $73,400,000 per fiscal year for fiscal years 2026 through 2031 to carry out the IMPROVE Initiative maternal health research program established in new 42 U.S.C. § 409K.
- Population Scope Medium Funds flow to researchers, grantees, and community organizations serving pregnant and postpartum women — the same bounded population as the programmatic mandate, well under 25% of the U.S. population.
- Budgetary Magnitude Medium Authorizes $73.4 million per year for six years ($440.4 million total), a recurring discretionary authorization of moderate scale within the broader National Institutes of Health (NIH) budget.
- Legal / Regulatory Depth Low Sets a dollar ceiling for an already-authorized program without altering substantive rights, duties, or enforcement authority — a narrow administrative act that constrains appropriators rather than changing underlying law.
- Degree of Discretion Granted Low The provision fixes a maximum annual figure with no delegated flexibility; actual spending is subject to the appropriations process, leaving no discretion within this clause itself.
- Implementation & Enforcement Burden Low An authorization ceiling creates no new enforcement mechanism, compliance requirement, or administrative infrastructure.
- Temporal Commitment Low The authorization expires by its own terms after FY2031 — a hard, six-year window that self-terminates unless Congress acts to extend it.
No signal yet
Funding / Appropriations
IMPROVE Initiative $73.4M annual authorization FY2026-2031
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: